Supply of Amlodipine Besylate 2.5 mg Tablets (90-count bottles)

The contract involves the manufacture and supply of low-dose amlodipine besylate 2.5 mg tablets, packaged in 90-count cylindrical bottles with child-resistant closures, barcoding for inventory and tracking, and design compatibility with automated dispensing systems. All packaging and labeling must meet rigorous pharmaceutical standards to ensure safety, accuracy, and seamless integration into healthcare distribution workflows. The product must comply with specifications for dosage, stability, and quality control, with strict adherence to regulatory requirements for pharmaceutical manufacturing. This is a subcontract under the Department of Defense’s DLA Troop Support, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing. The solicitation was posted on July 13, 2026, and responses are due by August 13, 2026. While no specific place of performance or point of contact is provided, the work is expected to support military healthcare logistics, requiring consistent supply Chain reliability and documentation. The packaging and labeling requirements emphasize operational readiness, ensuring the medication can be efficiently handled in both clinical and field settings.